Company Monitoring Page for Oncothyreon

latest headlines for company on cafepharma

With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
Endpoints
Wed, 12/7/16 - 10:16 am
Tags:
Oncothyreon, Cascadian, tucatinib, ONT-380, treatment-resistant breast cancer, breast cancer
Oncothyreon reports 2Q loss
Yahoo/AP
Fri, 08/7/15 - 08:48 am
Tags:
Oncothyreon, earnings
How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer
24/7 Wall St
Sun, 06/7/15 - 10:07 am
Tags:
biotech, ASCO, Immunogen, Exelixis, Oncothyreon, CTI BioPharma, Immunomedics, Vascular Biogenics
16 Biotech Stocks Moving Off The ASCO Conference
Yahoo/Benzinga
Tue, 06/2/15 - 10:06 am
Tags:
biotech, ASCO, Bristol-Myers Squibb, Immunogen, Oncothyreon, Clovis Oncology, CTI BioPharma, Exelixis, Roche, Amgen, AstraZeneca, Puma Biotechnology, Vascular Biogenics, Immunomedics, Momenta, Eli Lilly, Juno Therapeutics, Express Scripts
ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
TheStreet.com
Mon, 06/1/15 - 11:29 pm
Tags:
ASCO, Oncothyreon, Immunogen, Bristol-Myers Squibb, Merck, Clovis Oncology, Roche, CTI BioPharma, Celldex Therapeutics, Puma Biotechnology, Express Scripts
6 Key Cancer Winners From ASCO Presentations
24/7 Wall St
Mon, 06/1/15 - 10:06 am
Tags:
ASCO, Immunogen, mirevtuximab soravtansine, ONT-380, Oncothyreon, cabozantinib, Exelixis, VB-111, Vascular Biogenics, Immunomedics, sacituzumab govitecan, pacritinib, CTI BioPharma
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
TheStreet.com
Mon, 06/1/15 - 09:43 am
Tags:
Oncothyreon, breast cancer, ASCO, ONT-380, HER2-positive metastatic breast cancer
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek Pharmaceuticals (PRTK), Oncothyreon Inc. (ONTY), Tetraphase Pharmaceuticals (TTPH)
Bidness Etc.
Thu, 12/18/14 - 10:07 am
Tags:
Pozen, Tetraphase Pharmaceuticals, Paratek, Oncothyreon
Clinical failure for Merck KGaA's cancer vaccine dents subpopulation hopes
Fierce Biotech
Tue, 08/19/14 - 04:24 pm
Tags:
vaccines, Merck KGaA, Oncothyreon, non-small cell lung cancer, Stimuvax
Merck Launches Hail Mary Lung Cancer Trial
Motley Fool
Wed, 04/9/14 - 08:53 am
Tags:
Merck KGaA, tecemotide, Oncothyreon, non-small cell lung cancer
Oncothyreon is a potential target of Merck KGaA, says Cowen
Yahoo/Fly on the Wall
Wed, 09/25/13 - 10:33 am
Tags:
M&A, Oncothyreon, Merck KGaA
Merck KGaA to continue testing cancer vaccine
Reuters
Wed, 09/25/13 - 08:44 am
Tags:
vaccines, Merck KGaA, Stimuvax, Oncothyreon, non-small cell lung cancer
Oncothyreon A Speculative Buy
Seeking Alpha
Sat, 05/18/13 - 12:13 pm
Tags:
Oncothyreon
ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com
Thu, 05/16/13 - 10:38 am
Tags:
ASCO, lung cancer, vaccines, Oncothyreon, Stimuvax, Merck KGaA
Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Tue, 04/23/13 - 03:31 pm
Tags:
melanoma, vaccines, Amgen, Celldex, Oncothyreon, OncoSec, Vical
Oncothyreon Earnings: An Early Look
Motley Fool
Tue, 03/12/13 - 11:42 am
Tags:
earnings, Oncothyreon
A Triple Play Of Biotech Disappointments Last Week
Investopedia
Fri, 12/28/12 - 11:45 am
Tags:
Amicus, Hemispherx Biopharma, GSK, Oncothyreon
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 12/22/12 - 12:25 pm
Tags:
Oncothyreon, Amicus Therapeutics, Herbalife
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Tags:
Oncothyreon, Celsion, Arena Pharmaceuticals, NuPathe, Hemispherx, Amarin, Biogen Idec, Gilead, Hyperion Therapeutics, Celgene, Raptor Pharmaceuticals, Dynavax, Zogenix, Impax Labs
Merck KGaA expects to publish Stimuvax data in Q1 2013
Reuters
Thu, 11/15/12 - 11:09 am
Tags:
Merck KGaA, Stimuvax, vaccines, cancer, Oncothyreon

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.